Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY: DGX )

152.69 -0.72 (-0.47%)
Streaming Delayed Price Updated: 1:59 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 174,574
Open 152.41
Bid (Size) 152.63 (1)
Ask (Size) 152.86 (6)
Prev. Close 153.42
Today's Range 152.19 - 153.51
52wk Range 123.04 - 165.32
Shares Outstanding 122,180,759
Dividend Yield 1.96%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S. 
Via News Direct
Exposures Product Safety
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga

Performance

YTD
+8.43%
+8.43%
1 Month
-6.00%
-6.00%
3 Month
+0.13%
+0.13%
6 Month
+10.17%
+10.17%
1 Year
+11.65%
+11.65%

More News

Read More
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
From Mainz BioMed NV
Via GlobeNewswire
The Analyst Landscape: 8 Takes On Quest Diagnostics
Via Benzinga
(DGX) - Analyzing Quest Diagnostics's Short Interest
Via Benzinga
Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
Guardant Health Stock Sees RS Rating Jump To 83
Via Investor's Business Daily
Navigating Earnings Season: Weather Any Storm
Via Talk Markets
How Is The Market Feeling About Quest Diagnostics?
Via Benzinga
What Analysts Are Saying About Quest Diagnostics Stock
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics
Via Benzinga
Earnings Preview: Quest Diagnostics
Via Benzinga
Looking Into Quest Diagnostics's Recent Short Interest
Via Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Via Benzinga
Topics Government
Exposures Political
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
Via Benzinga
Topics Earnings
Exposures Financial
This Snap Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Decoding 7 Analyst Evaluations For Quest Diagnostics
Via Benzinga
What Analysts Are Saying About Quest Diagnostics Stock
Via Benzinga
Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025
Via Benzinga
Uber To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
Via Benzinga
8 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.